Sg3 Management, LLC Corcept Therapeutics Inc Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$16.53 - $25.21 $24,795 - $37,815	-1,500 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$17.1 - $23.34 $266,760 - $364,104	-15,600 Reduced 91.23%	1,500 $30,000
Q3 2021 Nov 15, 2021	SELL	$19.68 - $22.53 $1.25 Million - $1.43 Million	-63,400 Reduced 78.76%	17,100 $337,000
Q2 2021 Aug 16, 2021	BUY	$19.97 - $24.43 $932,039 - $1.14 Million	46,672 Added 137.97%	80,500 $1.77 Million
Q1 2021 May 17, 2021	BUY	$23.49 - $30.56 $559,719 - $728,183	23,828 Added 238.28%	33,828 $805,000
Q3 2020 Nov 13, 2020	BUY	$12.46 - $19.98 $124,600 - $199,800	10,000 New	10,000 $174,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.16B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.